Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Improving quality of life for patients with hypersensitivity pneumonitis

Official title: Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

Run by Weill Medical College of Cornell University · NCT06811389 · Data updated 2026-11-12

This study is testing a new support program that uses peer coaching to help people with hypersensitivity pneumonitis feel better and understand their condition more clearly.

More Hypersensitivity Pneumonitis trials

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment42 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 6, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedOctober 16, 2026
Trial IDNCT06811389 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with a documented diagnosis of hypersensitivity pneumonitis who are English-speaking and have access to a smartphone or tablet.

Probably not a fit

Patients with severe cognitive impairment or those experiencing severe depression may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention focuses on enhancing the health-related quality of life (HRQOL) for patients diagnosed with hypersensitivity pneumonitis through a peer coach-delivered program. The RISE-HP intervention combines cognitive behavioral principles with targeted patient education over ten sessions. It aims to address the emotional and informational needs of patients, who often experience anxiety and a lack of understanding about their condition. The study will assess the feasibility and accessibility of this innovative approach to patient support.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the quality of life for patients suffering from hypersensitivity pneumonitis.

How similar studies have gone: While this approach is innovative, similar interventions targeting quality of life improvements in chronic conditions have shown promise in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have documented diagnosis of Hypersensitivity Pneumonitis by treating clinician.
* Age 18 or older.
* English Speaking.
* Willing to work with a peer coach.
* Have a working smart phone or tablet.
* Have access to the internet.
* Reside or live in the United States.
* Endorse verbal approval from treating physician to participate in patients' goal movement/physical activity.
* Meet one or more of the following criteria:
* Baseline score on the PHQ8 of \<20

Exclusion Criteria:

* Does not have Hypersensitivity Pneumonitis
* Younger than age 18
* Severe cognitive impairment as determined by their treating physician.
* Participants with severe depression (PHQ-8 score ≥20) will be ineligible for the study and will be referred to alternative sources of care.
* Anyone with documentation in their medical chart of an eating disorder, active substance use disorder, suicidality, homicidality, acute posttraumatic stress disorder, or episodes of mania or psychosis.
* Anyone who is determined to be severely ill or moribund by the treating clinician.

Where it's running

  • Weill Cornell Medicine
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Kerri I Aronson, MD — Weill Medical College of Cornell University
  • Study coordinator: Meghana Ramineni, BA
  • Email: mer4025@med.cornell.edu
  • Phone: 646-962-8130

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Indoor environment assessment to help manage fibrosing hypersensitivity pneumonitis

    Aiming to see if an indoor environmental assessment by a specialized advisor can help manage fibrosing hypersensitivity pneumonitis in adults through home visits, antigen testing, and follow-up checks.

    Recruiting at 5 sites Nantes University Hospital · Nantes, Loire-Atlantique and 6 other locations · NCT05988437

  • Database and biobank for patients with hypersensitivity pneumonitis

    This study is collecting blood samples and health information from people with hypersensitivity pneumonitis to see how they compare to those with idiopathic pulmonary fibrosis and to help find better ways to diagnose and understand their condition.

    Recruiting University Hospital, Gentofte, Copenhagen · Hellerup, Copenhagen · NCT05549635

  • Biobank for interstitial lung diseases

    This study is setting up a collection of health information and samples from patients with interstitial lung diseases to help researchers learn more about the condition and find better treatments.

    Recruiting University of Kansas Medical Center · Kansas City, Kansas · NCT05392881

  • Examining muscle function in patients with interstitial lung disease

    This study tests how muscle function affects breathing and exercise in people with interstitial lung disease compared to healthy individuals, and looks at how supplemental oxygen might help.

    Recruiting University of British Columbia · Vancouver, British Columbia · NCT03800017

  • Identifying biomarkers for progressive pulmonary fibrosis in lung disease patients

    This study is trying to find early signs that can help predict if adults with certain lung diseases will develop progressive pulmonary fibrosis over the next five years.

    Recruiting Amsterdam UMC, location VUmc · Amsterdam, North Holland · NCT06644144

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.